The practicality of prescribing and administering biosimilars
Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
Renal complications in multiple myeloma - trials and next steps
FCR or FR – which regimen is better for treating CLL?
The ideal sequence: treating patients with CLL